| Efficacy and safety of the simultaneous administration of mirodenafil and an α-blocker in men with BPH-LUTS: a multicenter open-label prospective study. | |
| | |
MedLine Citation:
|
PMID: 23303333 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
We evaluated the clinical efficacy and safety of the coadministration of a PDE5 inhibitor and an α-adrenergic blocker in patients with both benign prostatic hyperplasia/lower urinary tract symptoms (BPH-LUTS) and ED using mirodenafil 50 mg (Mvixx) once daily (OD) in patients already receiving stable α-blocker therapy. This study was a prospective, multicenter, open-label trial. We selected 147 patients undergoing stable (longer than 4 weeks) α-blocker therapy for BPH-LUTS as recipients of the additive mirodenafil 50 mg OD for 8 weeks. The coprimary measures were the International Prostate Symptom Score (IPSS) and the International Index of Erectile Function (IIEF-5). The key secondary measures were peak flow rate (Q(max)) and postvoiding residual (PVR) volume. Safety was assessed by evaluating cardiovascular parameters and the participant-reported treatment-emergent adverse events (TEAEs). The additional administration of mirodenafil 50 mg OD significantly improved IPSS results (18.70-14.30 at 4 weeks and 18.70-13.72 at 8 weeks; P<0.001). The IIEF-5 score was improved at 8 weeks (10.94-16.16; P<0.001). There was no significant change in systolic blood pressure/diastolic blood pressure (124.8 mm Hg/78.6 mm Hg-122.0 mm Hg/79.6 mm Hg; P=0.638) and heart rates (78.8 per min to 80.2 per min; P=0.452). The most common TEAEs were hot flashes (10.9%) and headache (8.1%). The combination of mirodenafil with an α-blocker did not significantly improve PVR; however, Q(max) was improved at 8 weeks (14.51-16.80 ml s(-1); P=0.026). Mirodenafil 50 mg OD in combination with an α-blocker appeared to have few adverse effects, to improve BPH-LUTS and restore sexual function.International Journal of Impotence Research advance online publication, 10 January 2013; doi:10.1038/ijir.2012.44. |
| | |
Authors:
|
W J Bang; C Y Oh; C Yoo; J S Cho; D Y Yang; D H Lee; S H Lee; B H Chung |
Related Documents
:
|
17764013 - Boswellia serrata extract for the treatment of collagenous colitis. a double-blind, ran... 20359403 - An analysis of healthcare providers' online ratings. 18179733 - Effects of atomoxetine on attention-deficit/hyperactivity disorder in clinical pediatri... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2013-1-10 |
Journal Detail:
|
Title: International journal of impotence research Volume: - ISSN: 1476-5489 ISO Abbreviation: Int. J. Impot. Res. Publication Date: 2013 Jan |
Date Detail:
|
Created Date: 2013-1-10 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9007383 Medline TA: Int J Impot Res Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Department of Urology, Hallym University College of Medicine, Chuncheon, Korea. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: The impact of ankylosing spondylitis on female sexual functions.
Next Document: Gender difference in brain activation to audio-visual sexual stimulation; do women and men experienc...